Serum levels of vascular endothelial growth factor (VEGF) as a prognostic factor in renal cell carcinoma

Korean Journal of Urology

Volumn 48, Issue 12, 2007, Pages 1219-1223

  Kwon, Nam Sung ^a   Jo, Moon Ki ^a   Lee, Hyun Moo ^b  

^a Korea Cancer Center Hospital   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Prognosis; Renal cell carcinoma; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SURVIVAL RATE; UNIVARIATE ANALYSIS;

EID: 38049118029     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2007.48.12.1219     Document Type: Article

References (22)

1. Golimbu M, Joshi P, Sperber A, Tessler A, A1-Askari S, Morales P. Renal cell carcinoma: survival and prognostic factors. Urology 1986;27:291-301
2. Farber E. The multistep nature of cancer development. Cancer Res 1984;44:4217-23
3. Rini BI, Rathmell WK. Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma. Clin Cancer Res 2007;13:741s-6
4. Delahunt B. Histopathologic prognostic indicators for renal cell carcinoma. Semin Diagn Pathol 1998;15:68-76
5. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth in renal cell carcinoma associated with angiogenesis. Cancer Res 1994;54:4233-7
6. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8
7. Senger DR, Van De Walter L, Brown LF, Nagy JA, Yeo KT, Yeo TK, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993;12:303-24
8. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61
9. Nicol D, Hii SI, Walsh M, Teh B, Thompson L, Kennett C, et al. Vascular endothelial growth factor expression is increased in renal cell carcinoma. J Urol 1997;157:1482-6
10. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63
11. Zambrano NR, Lubensky IA, Merino MJ, Linehan WM, Walther MM. Histopathology and molecular genetics of renal tumors: toward unification of a classification system. J Urol 1999;162:1246-58
12. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal Cell carcinoma. A clinical and pathologic study Of 309 cases. Cancer 1971;28:1165-77
13. Patard JJ, Leray E, Cindolo L, Ficarra V, Rodriguez A, De La Taillle A, et al. Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol 2004;172: 858-62
14. Bouck N, Stellmach V, Hsu SC. How tumors become angiogenic. Adv Cancer Res 1996;69:135-74
15. Kim JN, Song KH, Song JM. Expression of vascular endothelial growth factor and its clinical significance with neovascularization in conventional renal cell carcinoma. Korean J Urol 2002;43:353-9
16. Ha HK, Ye JW, Lee SD, Chung MK. The relationship between expression of hypoxia inducible factor-la or vascular endothelial growth factor and histopathologic characteristics in human ranal cell carninoma. Korean J Urol 2004;45:303-8
17. Jacobsen J, Rasmuson T, Grankvist K, Ljungberg B. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. J Urol 2000;163:343-7
18. Sato K, Tsuchiya N, Sasaki R, Shimoda N, Satoh S, Ogawa O, et al. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma. Jpn J Cancer Res 1999;90:874-9
19. Schips L, Dalpiaz O, Lipsky K, Langner C, Rehak P, Puerstner P, et al. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group. Eur Urol 2007;51:168-74
20. Zhang J, Lefkowitz RA, Ishill NM, Wang L, Moskowitz CS, Russo P, et al. Solid renal cortical tumors: differentiation with CT. Radiology 2007;244:494-504
21. Douglas ML, Richardson MM, Nicol DL. Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma. Cancer 2004;100:2118-24
22. Beecken WD, Bentas W, Glienke W, Winneweber J, Jonas D, Binder J, et al. Serum angiogenic activity: diagnostic relevance in renal cell carcinoma. Eur Urol 2002;42:364-9